Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Stifel analyst Chris O’Cull upgraded Portillo’s (PTLO) to Buy from Hold with a price target of $16, up from $13. The firm previously downgraded ...

Stifel Nicolaus analyst Nathan Jones maintained a Buy rating on Veralto Corporation (VLTO – Research Report) on January 24 and set a price ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

After a painful crash early this season, Mikaela Shiffrin announced her return to the racecourse before the end of January.

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

Stifel analysts reiterated their Hold rating on Texas Instruments stock (NASDAQ:TXN) with a steady price target of $200.00.

Stifel analysts increased their price target for SEI Investments (NASDAQ:SEIC) (NYSE: SEI) shares to $42, up from the ...

Plby Group Inc (PLBY) stock saw a decline, ending the day at $1.81 which represents a decrease of $-0.04 or -2.16% from the prior close of $1.85. The stock opened at $1.84 and touched a low of $1.72 ...

In recent trading, shares of Stifel Financial Corp (Symbol: SF) have crossed above the average analyst 12-month target price of $116.00, changing hands for $116.23/share. When a stock reaches the ...